Average Co-Inventor Count = 8.95
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (13 from 3,923 patents)
2. Bausch + Lomb Ireland Limited (1 from 30 patents)
15 patents:
1. 12435040 - 1,3-substituted cyclobutyl derivatives and uses thereof
2. 11845730 - 1,3-substituted cyclobutyl derivatives and uses thereof
3. 10550102 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
4. 10208018 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
5. 9957254 - Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
6. 9765067 - Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
7. 9676728 - 2-benzyl-benzimidazole complement factor B inhibitors and uses thereof
8. 9475806 - Complement factor B inhibitors and uses there of
9. 9056874 - Complement pathway modulators and uses thereof
10. 8541432 - Heterobicyclic carboxamides as inhibitors for kinases
11. 8501756 - Heterobicyclic carboxamides as inhibitors for kinases
12. 8492393 - Heterobicyclic carboxamides as inhibitors for kinases
13. 8486954 - Heterobicyclic carboxamides as inhibitors for kinases
14. 8431584 - Heterobicyclic carboxamides as inhibitors for kinases
15. 8242125 - Heterobicyclic carboxamides as inhibitors for kinases